Friday 6 November 2026
Export WAY’s income statement to Excel — free account
Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
28.33
0.55
−1.90%
Follow WAY
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
36.12 | 28.51 | 34.44 | 51.17 |
+8 more quarters Free account |
P/S ratio |
3.85 | 3.27 | 4.00 | 5.30 | |
P/FCF ratio |
18.42 | 16.00 | 15.72 | 20.58 | |
P/Operating CF |
46.83 | 66.30 | 54.42 | 87.45 | |
P/B ratio |
1.20 | 0.99 | 1.17 | 1.50 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
4.77 | 4.30 | 5.10 | 6.55 | |
EV/EBITDA |
13.56 | 11.91 | 14.20 | 18.34 | |
EV/Operating CF |
19.14 | 17.68 | 17.87 | 23.24 | |
EV/FCF |
22.82 | 21.04 | 20.08 | 25.42 | |
Quick Ratio |
1.99 | 1.73 | 1.64 | 1.31 | |
Current Ratio |
2.10 | 1.85 | 1.76 | 1.41 | |
Net Debt/EBITDA |
11.24 | 10.51 | 10.46 | 13.69 | |
Debt/Assets |
24.71% | 24.99% | 25.17% | 25.46% | |
Debt/Equity |
0.36 | 0.37 | 0.37 | 0.38 | |
Asset Turnover |
0.24 | 0.23 | 0.22 | 0.21 | |
Operating CF/Net income |
3.35 | 1.45 | 1.96 | 3.33 | |
Capex/Depreciation |
(0.24) | (0.38) | (0.36) | (0.23) | |
Interest Coverage |
3.17 | 3.87 | 3.90 | 2.58 | |
Research and Development Expense of Revenue |
6.23% | 5.54% | 5.85% | 6.10% | |
Selling, General and Administrative Expense of Revenue |
31.75% | 27.14% | 24.39% | 30.61% | |
Intangible Assets out of Total Assets |
0.88 | 0.89 | 0.90 | 0.92 | |
Share Based Compensation of Revenue |
7.51% | 4.32% | 3.65% | 4.02% | |
Graham Net Nets |
(0.28) | (0.37) | (0.33) | (0.27) | |
Graham Number |
18.22 | 18.35 | 17.99 | 17.72 | |
Earnings Yield |
2.77% | 3.51% | 2.90% | 1.95% | |
Free Cash Flow Yield |
5.43% | 6.25% | 6.36% | 4.86% | |
Revenue per Share |
1.70 | 1.67 | 1.64 | 1.71 | |
Operating CF per Share |
0.54 | 0.31 | 0.44 | 0.37 | |
Capex per Share |
(0.05) | (0.08) | (0.08) | (0.05) | |
Free Cash Flow per Share |
0.49 | 0.23 | 0.36 | 0.32 | |
Cash per Share |
1.57 | 1.17 | 0.98 | 0.57 | |
Shareholders Equity per Share |
21.03 | 20.78 | 20.54 | 21.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
21.03 | 20.78 | 20.54 | 21.80 | |
Free Cash Flow |
93.94 | 43.30 | 69.59 | 57.22 | |
Working Capital |
270.28 | 201.25 | 166.65 | 90.35 | |
Capital Expenditures |
(9.92) | (16.11) | (15.33) | (9.41) | |
Net Current Asset Value |
(1,370.80) | (1,443.54) | (1,514.94) | (1,597.86) | |
EV/EBIT |
21.77 | 18.79 | 22.31 | 28.87 | |
Capex to Sales |
0.03 | 0.05 | 0.05 | 0.03 | |
Price to Operating Income |
17.57 | 14.28 | 17.47 | 23.37 | |
| Other line items | |||||
Average Receivables |
166.34 | 164.69 | 159.90 | 165.77 | |
Average Payables |
59.74 | 51.48 | 51.93 | 49.16 | |
Average Assets |
5,334.60 | 5,273.34 | 5,229.09 | 5,181.05 | |
Average Common Equity |
3,629.59 | 3,579.69 | 3,531.68 | 3,479.31 |
Columns are period end dates · fundamentals updated 5 Nov 2026